Tops & Flops Stocks
| Security | Change (%) ▲ | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Aceragen Inc. | -39.430% | - | - | - | - | - | - |
| Endo International | -16.670% | - | - | - | - | - | - |
| Fortress Biotech Inc. | -12.900% | - | - | - | - | - | - |
| Bellicum Pharmaceuticals Inc. | -9.290% | - | - | - | - | - | - |
| Neos Therapeutics Inc | -8.590% | - | - | - | - | - | - |
| Curis Inc. | -8.090% | - | - | - | - | - | - |
| Durect Corp. | -8.040% | - | - | - | - | - | - |
| Cara Therapeutics Inc. | -6.810% | 3.678% | 16.349% | -79.129% | 5.696% | -93.342% | -95.611% |
| Organovo Holdings Inc. | -4.960% | 14.937% | -8.364% | -40.000% | -1.754% | -83.297% | -94.260% |
| Cumberland Pharmaceuticals | -4.690% | - | - | - | - | - | - |
| Spectrum Pharmaceuticals | -4.190% | - | - | - | - | - | - |
| Lexicon Pharmaceuticals Inc. | -3.810% | -4.453% | 6.306% | -40.576% | 19.710% | -52.988% | -71.727% |
| Omeros Corp. | -3.770% | -12.275% | 6.799% | -47.684% | -3.765% | -77.905% | -81.587% |
| Codexis Inc. | -3.680% | -0.479% | 26.657% | 38.989% | 17.776% | -78.679% | -80.865% |
| Acelrx Pharmaceuticals Inc. | -3.660% | 1.283% | 4.066% | 30.982% | 33.757% | -95.284% | -98.056% |
| ImmunityBio Inc. | -3.440% | -20.015% | 29.381% | 133.358% | 35.466% | -54.040% | - |
| Minerva Neurosciences Inc. | -3.420% | -3.361% | -1.709% | -58.744% | -60.583% | -89.969% | - |
| Pieris Pharmaceuticals Inc | -2.980% | - | - | - | - | - | - |
| Acorda Therapeutics Cdt | -2.970% | - | - | - | - | - | - |
| Rhythm Pharmaceuticals | -2.780% | -1.685% | -2.235% | 125.806% | -17.840% | - | - |
| Akebia Therapeutics Inc. | -2.750% | -8.473% | -14.230% | 1.019% | -6.911% | -61.853% | - |
| Verastem Inc. | -2.750% | -4.505% | 15.217% | 127.898% | 40.397% | -66.104% | - |
| Puma Biotechnology Inc. | -2.710% | -14.790% | -13.665% | 58.438% | 3.867% | -52.639% | - |
| Syndax Pharmaceuticals Inc | -2.670% | -10.476% | -7.843% | -3.093% | 0.535% | 28.767% | - |
| Adverum Biotechnologies Inc. | -2.650% | - | - | - | - | - | - |